Scientists believe they have discovered a special antibody which may lead to a treatment for Retinitis Pigmentosa, a condition that causes loss of central vision, as well as night and color vision. A ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted fast track designation to MCO-010 from Nanoscope Therapeutics for the treatment of retinitis ...
BLOOM (TAMPA) – In a recent episode of the global health and wellness show Bloom, Gayle Guyardo interviewed Dr. Oleg Alekseev, MD, PhD, a renowned Retina Specialist at Duke Eye Center. Dr. Alekseev ...
Sustained LLVA responder rates at 12 months reinforced the earlier 9-month signal and aligned with the endpoints selected for ...
Please provide your email address to receive an email when new articles are posted on . QR-1123, a first-in-class investigational antisense oligonucleotide for the treatment of vision loss associated ...
PYC Therapeutics Limited (AU:PYC) has released an update. PYC Therapeutics has announced positive results from its ongoing clinical trials for VP-001, a treatment for the childhood blinding disease ...
Treatment with bioavailable small-molecule pharmacochaperones targeting the visual receptor rhodopsin offers a promising approach to prevent retinal photoreceptor degeneration caused by inherited ...
ITHACA, N.Y. -- The English mastiff dog, a breed that sometimes carries the gene defect for the canine eye disease progressive retinal atrophy (PRA), has been revealed as a key animal model to help ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated ...
Retinitis pigmentosa is a degenerative disease affecting the photoreceptor cells in the retina, known as cones and rods. Of genetic origin, this disease first affects vision in low light conditions, ...
Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds, described in a study published January 14 th in the open-access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results